dysplasia

(redirected from Arrhythmogenic right ventricular dysplasia)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Arrhythmogenic right ventricular dysplasia: Arrhythmogenic right ventricular cardiomyopathy

dys·pla·sia

 (dĭs-plā′zhə)
n.
Abnormal development or growth of tissues, organs, or cells.

dys·plas′tic (-plăs′tĭk) adj.

dysplasia

(dɪsˈpleɪzɪə)
n
(Anatomy) abnormal development of an organ or part of the body, including congenital absence
[C20: New Latin, from dys- + -plasia, from Greek plasis a moulding]
dysplastic adj

dys•pla•sia

(dɪsˈpleɪ ʒə, -ʒi ə, -zi ə)

n.
abnormal growth or development of cells, tissue, bone, or an organ.
[1930–35; dys- + -plasia]
dys•plas′tic (-ˈplæs tɪk) adj.

dys·pla·sia

(dĭs-plā′zhə)
Abnormal development or growth of tissues, organs, or cells.

dysplastic adjective
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.dysplasia - abnormal development (of organs or cells) or an abnormal structure resulting from such growth
aplasia - failure of some tissue or organ to develop
fibrous dysplasia of bone - a disturbance in which bone that is undergoing lysis is replaced by an abnormal proliferation of fibrous tissue resulting in bone lesions or skin lesions
hypertrophy - abnormal enlargement of a body part or organ
hyperplasia - abnormal increase in number of cells
hypoplasia - underdevelopment of an organ because of a decrease in the number of cells
anaplasia - loss of structural differentiation within a cell or group of cells often with increased capacity for multiplication, as in a malignant tumor
abnormalcy, abnormality - an abnormal physical condition resulting from defective genes or developmental deficiencies
Translations
dysplasie

dys·pla·si·a

n. displasia, cambio o desarrollo anormal de los tejidos.

dysplasia

n displasia, desorden f de crecimiento en un tejido
References in periodicals archive ?
In 2012-2013, several research groups obtained cell models of inherited arrhythmogenic right ventricular dysplasia (ARVD) and dilated (DCMP) and hypertrophic (HCMP) cardiomyopathies using patient-specific iPSCs (see Table 5) [31,48-52].
1-3,6-8) The term arrhythmogenic right ventricular dysplasia without the additional designation of cardiomyopathy was originally proposed because the disease appeared to be a developmental abnormality, which was supported by its similarity to Uhl anomaly.
The heart condition is known as arrhythmogenic right ventricular dysplasia (ARVD) [1-2].
Since the incorporation of the ECG in Italy in 1986 by law, the prevalence of athletic SCD death decreased by nearly 90% in a small part of Italy and was attributed mostly to early identification of arrhythmogenic right ventricular dysplasia (ARVD) [2].
This condition must be distinguished from other established clinical entities presenting prominent trabeculations including: apical hyperthrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular dysplasia and endocardial fibroelastosis.
Cardiomyopathies such as hypertrophic cardiomyopathy, dilated cardiomyopathy and arrhythmogenic right ventricular dysplasia account for approximately 10-15 per cent of sudden deaths (2).
Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia.
The screening program was predicated on an unusually high incidence of arrhythmogenic right ventricular dysplasia (ARVD) in the region, however, and the 89% drop reported in the JAMA study brings the rate of sudden cardiac death in the region "to about what we see in our country," Dr.

Full browser ?